Golden
ViaCyte

ViaCyte

ViaCyte is a biotechnology company using stem cells to create pancreatic beta cell precursors for treating diabetes.

ViaCyte is a biotechnology company using stem cells to create pancreatic beta cell precursors for treating diabetes that is headquartered in San Diego, California and was founded in 1999 by Paul Laikind.

Timeline

People

Name
Role
Related Golden topics







Further reading

Title
Author
Link
Type
Date

$10 Million Grant to ViaCyte from Gore Supports Cell-Based Treatment for Diabetes

Beyondtype1

Web



Center for Beta Cell Therapy in Diabetes and ViaCyte Announce Start of European Clinical Trial of Human Stem Cell-derived Implants in Type 1 Diabetes Patients

ViaCyte, Inc.

Web



ViaCyte encapsulated islet cells show survival success in type 1 diabetes trial

Benedict Jephcote

Web



ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes

ViaCyte, Inc.

Web



Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services